Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Benign Prostatic Hyperplasia (BPH) is a noncancerous enlargement of the prostate gland that commonly affects men as they age. While BPH is primarily diagnosed through physical examination and symptom assessment, blood testing plays an important supporting role in monitoring prostate health and ruling out other conditions.
This highly sensitive PSA test can detect elevated levels of prostate-specific antigen that may be associated with benign prostatic hyperplasia. While BPH itself causes noncancerous prostate enlargement, monitoring PSA levels helps healthcare providers assess prostate health and differentiate between benign conditions and potential malignancies.
There is no single blood test that definitively diagnoses BPH itself. However, lab testing is fundamental for assessing overall prostate health, monitoring the body's response to the condition, and helping healthcare providers distinguish between BPH and other prostate-related issues, including prostate cancer.
PSA (Prostate-Specific Antigen) is a protein produced by prostate cells. Both cancerous and noncancerous conditions, including BPH, can cause PSA levels to rise. This is why PSA testing, combined with clinical evaluation, is valuable for comprehensive prostate health assessment in men with enlarged prostate symptoms.
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment.